If your antibiotics aren’t clearing an infection, the single most important step is to contact your prescribing doctor rather than wait it out. Antibiotic failure is common, and it doesn’t always mean you’re dealing with a resistant superbug. The causes range from the wrong antibiotic being chosen initially to the infection not being bacterial at all. Understanding why treatment fails, and what comes next, can help you have a more productive conversation with your doctor and get to the right solution faster.
Why Antibiotics Fail
Most people assume antibiotic failure means the bacteria are resistant to the drug. That’s one possibility, but research shows it’s frequently not the explanation. A 2025 review in Drug Resistance Updates found that failed antibiotic treatment often cannot be attributed to genetically encoded resistance at all. Several other factors play a bigger role than many patients realize.
The most straightforward reason is a mismatch: doctors typically prescribe antibiotics based on the most likely cause of your infection before lab results come back. This educated guess works most of the time, but not always. The bacteria causing your infection may simply not be vulnerable to the specific drug you were given. In other cases, the infection isn’t bacterial in the first place. Viral infections, fungal infections, and inflammatory conditions can all mimic bacterial infections, and antibiotics do nothing against any of them.
A less obvious cause is something called biofilm. Bacteria can form colonies coated in a sticky, protective matrix made of proteins, sugars, and DNA. This shield physically blocks antibiotics from reaching the bacteria inside. The matrix can absorb up to 25% of its own weight in antibacterial molecules, essentially soaking up the drug before it can do its job. Biofilms are especially common on medical implants like joint replacements, catheters, and heart valves, but they also form in chronic wounds and sinus infections. Bacteria living in biofilms behave differently from free-floating bacteria. They slow their metabolism and essentially hunker down, which makes them far harder to kill even with the right antibiotic.
Your immune system also matters more than most people think. Antibiotics don’t work alone. They cooperate with your body’s immune response to clear infections. If your immune system is weakened by medications, chronic illness, or even severe stress, antibiotics may not get enough backup to finish the job.
What Your Doctor Will Do Next
When you report that your symptoms aren’t improving, your doctor’s first job is figuring out why. This usually means a more targeted diagnostic workup rather than simply switching to a stronger drug. The goal is to avoid what researchers call “needless, expensive, and potentially dangerous” changes in therapy.
The cornerstone of this process is a culture and susceptibility test. Your doctor collects a sample (urine, blood, wound swab, sputum) and sends it to a lab where technicians grow the bacteria and expose them to different antibiotics. The most common method, used since the 1940s, involves placing small antibiotic-soaked disks on a plate of bacteria and measuring how far the drug’s killing zone extends. Results typically take 18 to 48 hours. A newer variation uses gradient strips that reveal not just whether an antibiotic works, but the precise concentration needed. These tests take the guesswork out of treatment by identifying exactly which drugs your specific bacteria are vulnerable to.
Your doctor will also reassess the diagnosis itself. Blood markers of inflammation and infection can help distinguish a bacterial infection from a viral one or from a non-infectious condition causing similar symptoms. Imaging like X-rays, CT scans, or ultrasounds may be ordered to check whether there’s an abscess or a deeper source of infection that antibiotics alone can’t reach.
How Treatment Changes
Once your doctor has better information, the path forward usually falls into one of a few categories.
If the original antibiotic was simply the wrong match, you’ll be switched to one your bacteria are susceptible to. This is the most common and straightforward fix. For many infections, the new antibiotic will still be an oral pill. Current guidelines from the Infectious Diseases Society of America emphasize that switching to or staying on oral therapy is preferred whenever the bacteria are susceptible to an oral drug, you’re otherwise stable, and your gut can absorb the medication normally.
If the infection is more serious or caused by highly resistant bacteria, intravenous antibiotics may be necessary. IV delivery bypasses absorption issues and achieves higher drug concentrations in the blood and tissues. For some of the most resistant infections, doctors use combination therapy, hitting the bacteria with two or more antibiotics simultaneously to overwhelm its defenses.
If a physical source is fueling the infection, such as an abscess, an infected implant, or a pocket of pus, no antibiotic will work until that source is addressed. This is called source control, and it might mean draining an abscess, removing an infected device, or a surgical procedure to clean out infected tissue.
Timing and Duration Matter
One underappreciated reason antibiotics fail is that they weren’t taken correctly. Skipping doses, taking them at uneven intervals, or stopping early because you feel better can all leave enough bacteria alive to rebound. That said, “always finish the full course” is more nuanced than the old advice suggested.
Current guidelines from major medical societies recommend surprisingly short courses for many common infections. Uncomplicated urinary tract infections in otherwise healthy women need only 3 to 5 days of treatment. Acute sinusitis calls for 5 to 7 days, with a reassessment at day 3 to 5. Community-acquired pneumonia requires at least 5 days, with the key benchmark being 48 to 72 hours of clinical stability before stopping. Uncomplicated skin infections like cellulitis are treated for 5 days initially, extending to 10 only if there’s no improvement.
The flip side of timing is equally important: delays in starting the right antibiotic make outcomes dramatically worse. Research on severe infections found that every hour of delay in starting appropriate antibiotic treatment increases the risk of death by 7.6%. This is why calling your doctor promptly when treatment isn’t working matters so much. Waiting days to see if things improve on their own costs valuable time.
Warning Signs That Need Urgent Attention
Most antibiotic failures are inconvenient but not emergencies. Some, however, signal that an infection is progressing dangerously. The onset of these signs is often gradual rather than sudden, which makes them easy to dismiss.
Watch for mental fogginess or confusion that wasn’t there before, fever that returns or spikes after initially improving, a noticeable drop in how much you’re urinating, persistent low blood pressure (feeling lightheaded or dizzy when standing), and a heart rate that stays elevated even at rest. These can indicate sepsis, a life-threatening escalation where the infection triggers a destructive chain reaction throughout the body. If untreated, it can progress to organ failure. Any combination of these symptoms while you’re on antibiotics warrants emergency care, not a scheduled appointment.
The Resistance Problem Is Growing
Antibiotic resistance is not a distant, theoretical threat. A 2025 CDC report found that infections from one of the most dangerous classes of resistant bacteria, NDM-producing carbapenem-resistant Enterobacterales, surged more than 460% in the United States between 2019 and 2023. These bacteria resist nearly every available antibiotic. In 2020 alone, carbapenem-resistant infections caused roughly 12,700 infections and 1,100 deaths in the U.S.
This trend means the scenario of antibiotics not working is becoming more common, not less. It also means the diagnostics described above, particularly culture and susceptibility testing, are increasingly essential rather than optional.
Treatments Beyond Traditional Antibiotics
For infections that resist all standard antibiotics, a newer option is gaining traction: bacteriophage therapy. Phages are viruses that infect and kill specific bacteria while leaving human cells untouched. Hundreds of patients with multidrug-resistant infections are now receiving phage therapy each year in the U.S. and Europe under expanded access programs supervised by the FDA and European regulators.
The results so far are encouraging. One major center reported that among 30 patients treated under compassionate-use protocols, 21 achieved bacterial eradication, though 6 of those relapsed within three months. Safety outcomes across more than 100 FDA-approved treatments have been excellent. Phage therapy remains investigational, meaning it’s not yet something you can simply request at your local clinic. It’s primarily available for patients with serious resistant infections who have exhausted other options. Multiple clinical trials are underway or opening soon, including trials for prosthetic joint infections and lung infections in cystic fibrosis patients. Malaysia launched a national phage therapy initiative in 2025 that could serve as a model for broader adoption worldwide.
Access to phage therapy typically requires a referral to a specialized center, and finding the right phage for your specific bacteria takes screening. Of nearly 900 requests at one U.S. program, active phages were identified for about a third of cases. It’s not a universal solution yet, but for patients facing infections that nothing else can treat, it represents a real and growing option.